Hui Liu

Hui Liu

Auto-generated profile, based on publicly available information

Hui Liu

Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, No. 251, Fukang Road, Xiqing District, Tianjin, 300384, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2020 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
HLHui Liu
Hui Liu
FGFrank Gambino
Frank Gambino
CACrystal S. Algenio
Crystal S. Algenio
CWCharles Wu
Charles Wu
YGYichen Gao
Yichen Gao
SZShaozhen Zhao
Shaozhen Zhao

24 September 2024 in Transplantation
Verified
Journal Article
Closed access
XCXiaoran Chu
Xiaoran Chu
YYYilan Mmed Yin
Yilan Mmed Yin
SCSijing Chen
Sijing Chen
FCFu Mmed Chen
Fu Mmed Chen
HLHui Liu
Hui Liu
SZShaozhen Zhao
Shaozhen Zhao
Background.: Immunological rejection is the most common reason for corneal transplantation failure. The importance of T cells in corneal allograft rejection is well demonstrated. Recent studies highlight that pigment epithelium-derived factor (PEDF) plays an immunoregulatory role in ocular diseases by enhancing the suppressive phenotype of regulatory T cells besides its other functions in neurotrophy and antiangiogenesis. Methods.: The effects of PEDF on immune rejection were examined in rat models of corneal transplantation using slit-lamp microscope observation, immunohistochemistry, flow cytometry, and Western blot. In vitro, we demonstrated PEDF reduced alloreactive T-cell activation using real-time polymerase chain reaction, flow cytometry, and Western blot. Results.: Topical administration of PEDF provided corneal transplantation rats with an improved graft survival rate of corneal allografts, reduced hemangiogenesis, and infiltration of immune cells in corneas, in particular, type 17 T helper cells while increased regulatory T cells. Moreover, nerve reinnervation within grafts was promoted in PEDF-treated recipient rats. In vitro, PEDF inhibited alloreactive T-cell activation via the c-Jun N-terminal kinase/c-Jun signaling pathway and upregulated the expressions of interleukin-10 and transforming growth factor-β, emphasizing the suppressive role of PEDF on immune responses. Conclusions.: Our results underscore the feasibility of PEDF in alleviating corneal allograft rejection and further illustrate its potential in managing immune-related diseases.

13 February 2026 in Experimental Eye Research
Verified
Journal Article
Closed access
YYYiyun Yue
Yiyun Yue
YXYan Xu
Yan Xu
MYMingyi Yu
Mingyi Yu
ZFZijie Fang
Zijie Fang
YHYue Huang
Yue Huang
SZShaozhen Zhao
Shaozhen Zhao

18 August 2026 in International Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
AXAn-Ran Xuan
An-Ran Xuan
YZYa-Ning Zhang
Ya-Ning Zhang
CZChen Zhang
Chen Zhang
RYRui-Bo Yang
Rui-Bo Yang
YHYue Huang
Yue Huang
SZShaozhen Zhao
Shaozhen Zhao
AIM: To compare the efficacy, safety, visual outcomes, satisfaction, and comfort of three-dimensional (3D) heads-up visualization system-assisted and conventional microscopic implantable Collamer lens (ICL) surgery. METHODS: Patients undergoing ICL or Toric ICL (TICL) implantation were enrolled and randomized into two groups: TM group (under a conventional microscope) and 3DM group (under NGENUITY 3D visualization system). Ocular parameters were assessed preoperatively and at 1wk, 1, 3, and 6mo postoperatively. The duration of key surgical steps and the incidence of complications were recorded. Patient-reported outcomes (dry eye, visual quality, comfort) and surgeon satisfaction were assessed using standardized questionnaires. RESULTS: The study included 98 eyes of 98 refractive error patients (17 males), 50 eyes in TM group (age 27.74±5.65y), and 48 eyes in 3DM group (age 29.20±4.89y). Efficacy, safety, quality of vision (QoV), dry eye symptoms, and patients’ satisfaction at 6mo were not significant across the time points of 1wk, 1, 3 and 6mo. No complication was observed in either group. The 3DM group was associated with a longer main step operation time (P=0.037) but better patient visual comfort (P<0.001). The difference in surgical fluency was not statistically significant (P=0.067). Notably, surgeons reported no delays or discomfort and rated the 3DM system significantly higher in image resolution, range of view, depth perception, color contrast, and postural comfort (all P<0.001). CONCLUSION: For ICL surgery, the use of the NGENUITY 3D visualization system achieves comparable surgical efficacy, safety, and patient satisfaction to procedures performed under a traditional microscope, while delivering superior intraoperative visual performance and postural comfort for the surgeon. These ergonomic and visual advantages make it a promising tool for enhancing clinical practice and surgical training.